The Pharmaceutical Research and Manufacturers of America (PhRMA) today released new advertising as part of its "From Hope to Cures" campaign, highlighting two patient stories that exemplify the theme of ACHIEVABLE.
The first set of new ACHIEVABLE print and digital ads feature Ed. In 2008, doctors found a three-inch tumor that threatened Ed's life. Today, he is a colon cancer survivor. The campaign shares Ed's story, the various treatments he's undergone and how he now spends his life educating Americans about the warning signs for colon cancer.
Other new print ads for ACHIEVABLE share Roxanne's story of living with heart disease. She did not know she had experienced a silent heart attack until six weeks after it happened. Now a heart transplant recipient, Roxanne is a survivor who is spreading the word about heart disease.
The release of these new ads marks the fourth part of the 2016 "From Hope to Cures" campaign. Throughout the year, digital and print ads and videos have centered on the themes of HOPE, COURAGE and SOLVABLE, building on the 2015 themes of POSSIBLE, CURABLE and POWER.
The campaign has highlighted the stories of Rhys, a five-year-old living with type 1 diabetes and celiac disease; Jamie, a woman battling a rare blood cancer; and Matt, a lung cancer survivor. The campaign has also featured a number of biopharmaceutical researchers, including Jen and Yingzi, oncology researchers, and Kelly, Wei and Kalpana who are working to develop new breakthroughs in immuno-oncology treatments.
"From Hope to Cures" launched in January 2014 to highlight the value biopharmaceutical innovation provides to patients, society and the economy. The campaign website features stories of real patients and researchers, data and information on fighting diseases and an interactive map showing the economic contributions of the industry.
PhRMA Releases New Patient Stories in Last Installment of 2016 "From Hope to Cures" Advertising Campaign
Read Next
Only 53% of marketers get meaningful ROI from AI, TransUnion finds
Survey of 100 US marketing leaders puts data and process readiness at 36% while 89% raise AI budgets. Fragmented data now shapes who scales AI and who stalls.
PubMatic guardrails block AI agents from unapproved ad inventory
Agents halt mid-flight when a required approval field is empty, and every action is logged for buyers. Rise piloted it. Can an audit trail win agentic spend?
New York Times digital ad revenue gains 20.7% to $114 million in Q2
Marketer demand beat guidance again as print ads fell 11.1% to $35.2 million. Adjusted costs grew 10%. Q3 guidance points to slower mid-to-high-teens growth.
Google says targets become the efficiency lever in budget-capped campaigns
Smec's Mike Ryan calls August 17 no cliff and allows 30 to 60 days to read results, hours before Google posted its FAQ. Which auctions do campaigns enter next?
53% of holiday shoppers will buy only from last year's stores, Optimove finds
Seventy-two percent now consult ChatGPT, Claude or Gemini for gift ideas, and 55% plan bigger budgets. Privacy remains the main barrier to wider AI adoption.
Brave Search gains a spot on Chrome's engine list at 2.46 billion queries
Browser hit 122.55 million monthly users in July, up 1.3% on June, with 51 million daily. Whether a listing shifts a browser holding 1% of traffic is untested.
Reddit loses search traffic as Google denies any ranking preference
Jennifer Kutz says Google AI features target no single platform, days after Reddit stock fell 12.49% on referral fears. But does a $60m data deal test that?
Blogger owners face 89-day deletion clock as Google malware flags misfire
Google says a bug wrongly flagged some Blogger sites as malware for under a day. Sites aged 12 and 18 years were locked. No count of affected blogs was given.
Amazon puts Sponsored Products into creator hands on August 10
Amazon extends Sponsored Products into creator content on August 10, enrolling live campaigns at current bids while creators pick which products they feature.
Meta puts AI ahead of support tickets for developers by mid-September
Assistant now fields app review, business verification and API permission queries in plain language. Meta claims approval-rate gains but publishes no figures.
Subscribe to Newsletter
Every morning, get a curated digest of the last 24 hours in programmatic advertising
Discussion